Pasithea Therapeutics (KTTA) Short Interest Ratio & Short Volume $3.21 +0.02 (+0.63%) (As of 02:28 PM ET) Add Compare Share Share Short Interest Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestTrends Pasithea Therapeutics Short Interest DataPasithea Therapeutics (KTTA) has a short interest of 11,600 shares, representing 1.45% of the float (the number of shares available for trading by the public). This marks a -49.12% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.0, indicating that it would take 0.0 days of the average trading volume of 284,942 shares to cover all short positions.Current Short Interest11,600 sharesPrevious Short Interest22,800 sharesChange Vs. Previous Month-49.12%Dollar Volume Sold Short$44,080.00Short Interest Ratio0.0 Days to CoverLast Record DateOctober 31, 2024Outstanding Shares1,270,000 sharesFloat Size802,500 sharesShort Percent of Float1.45%Today's Trading Volume29,531 sharesAverage Trading Volume284,942 sharesToday's Volume Vs. Average10% Short Selling Pasithea Therapeutics? Sign up to receive the latest short interest report for Pasithea Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartKTTA Short Interest Over TimeKTTA Days to Cover Over TimeKTTA Percentage of Float Shorted Over Time Ad Darwin2025 AI Stock Picks: 2 Hidden Gems Under $10/ShareThe AI sector continues to make waves as we move into 2025, and now is a prime opportunity to get involved—without stretching your budget! We’ve just uncovered 2 promising AI stocks trading for under $10/share, and they’re positioned for impressive growth in the coming months.👉[Click here to get your FREE report delivered instantly!] Pasithea Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 10/31/202411,600 shares $44,080.00 -49.1%1.5%0 $3.80 10/15/202422,800 shares $90,060.00 -86.7%2.8%0 $3.95 9/30/2024171,300 shares $928,446.00 +42,725.0%21.4%0.2 $5.42 9/15/2024400 shares $1,548.00 -90.7%0.1%0 $3.87 8/31/20244,300 shares $19,570.16 -45.6%0.5%0.3 $4.55 8/15/20247,900 shares $36,261.00 +182.1%1.0%0.7 $4.59 Get the Latest News and Ratings for KTTA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Pasithea Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 7/31/20242,800 shares $14,700.00 -31.7%0.4%0.3 $5.25 7/15/20244,100 shares $24,846.41 -34.9%0.6%1.2 $6.06 6/30/20246,300 shares $31,882.41 -28.4%0.9%2.2 $5.06 6/15/20248,800 shares $46,288.00 -8.3%1.2%2.7 $5.26 5/31/20249,600 shares $52,416.00 -4.0%1.3%4.2 $5.46 5/15/202410,000 shares $66,500.00 No Change1.3%4.8 $6.65 4/30/202410,000 shares $69,200.00 No Change1.3%3 $6.92 4/15/202410,000 shares $71,500.00 +14.9%1.3%2 $7.15 3/31/20248,700 shares $63,077.61 +3.6%1.2%1 $7.25 3/15/20248,400 shares $58,575.72 -8.7%0.1%0.7 $6.97 2/29/20249,200 shares $73,600.00 +4.6%0.1%0.1 $8.00 2/15/20248,800 shares $62,524.00 -5.4%0.1%0.1 $7.11 1/31/20249,300 shares $60,915.00 -31.1%0.1%0.1 $6.55 1/15/202413,500 shares $101,385.00 +29.8%0.1%0.2 $7.51 12/31/202310,400 shares $76,960.00 -98.1%0.1%0.1 $7.40 12/15/2023539,600 shares $188,860.00 +1,652.0%3.6%0.3 $0.35 11/30/202330,800 shares $10,040.80 -13.7%0.2%0.8 $0.33 11/15/202335,700 shares $11,781.00 -2.5%0.2%1.2 $0.33 10/31/202336,600 shares $12,810.00 -13.3%0.2%1 $0.35 10/15/202342,200 shares $18,568.00 +29.5%0.2%0.8 $0.44 9/30/202332,600 shares $15,638.22 -40.0%0.2%0.2 $0.48 9/15/202354,300 shares $27,150.00 -55.7%0.3%0.3 $0.50 8/31/2023122,600 shares $74,234.30 -24.1%0.6%0.6 $0.61 8/15/2023161,500 shares $97,788.25 +111.1%0.8%0.7 $0.61 7/31/202376,500 shares $45,754.65 +4.2%0.4%0.3 $0.60 7/15/202373,400 shares $34,211.74 -26.0%0.4%0.3 $0.47 6/30/202399,200 shares $48,608.00 -32.4%0.5%0.8 $0.49 6/15/2023146,800 shares $67,997.76 +149.2%0.8%1.6 $0.46 5/31/202358,900 shares $20,615.00 -2.0%0.3%0.7 $0.35 5/15/202360,100 shares $21,041.01 +39.4%0.3%1.2 $0.35 4/30/202343,100 shares $15,080.69 +24.9%0.2%0.7 $0.35 4/15/202334,500 shares $13,458.45 +37.5%0.2%0.5 $0.39 3/31/202325,100 shares $9,412.50 -60.8%0.2%0.3 $0.38 3/15/202364,100 shares $30,133.41 +357.9%0.5%0.7 $0.47[625,000% Gain] – Are You Ready for the Next Altcoin Boom? (Ad)All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen.Register for the FREE Workshop Now & get $10 in Bitcoin 2/28/202314,000 shares $6,721.40 +25.0%0.1%0.1 $0.48 2/15/202311,200 shares $6,287.74 -78.8%0.1%0.1 $0.56 1/31/202352,900 shares $37,180.77 -64.2%0.4%0.6 $0.70 1/15/2023147,900 shares $103,027.29 -12.9%1.1%2.1 $0.70 12/30/2022169,800 shares $108,960.66 -13.7%1.3%1.8 $0.64 12/15/2022196,700 shares $155,786.40 -6.2%1.5%1.8 $0.79 11/30/2022209,800 shares $207,743.96 +10.8%1.6%1.9 $0.99 11/15/2022189,300 shares $194,979.00 -16.1%1.5%1.4 $1.03 10/31/2022225,600 shares $245,904.00 -36.8%1.7%0.5 $1.09 10/15/2022356,700 shares $445,875.00 +44.1%2.7%0.7 $1.25 9/30/2022247,600 shares $311,976.00 -17.0%1.7%0.5 $1.26 9/15/2022298,200 shares $357,840.00 +20.2%2.0%0.6 $1.20 8/31/2022248,200 shares $285,430.00 -69.0%1.7%0.5 $1.15 8/15/2022800,000 shares $1.04 million +386.0%5.5%1.7 $1.30 7/31/2022164,600 shares $190,936.00 +13.4%1.5%1 $1.16 7/15/2022145,200 shares $162,624.00 -23.9%1.3%0.9 $1.12 6/30/2022190,900 shares $192,809.00 -9.3%1.7%1.3 $1.01 6/15/2022210,400 shares $212,504.00 +124.6%1.5%1.2 $1.01 5/31/202293,700 shares $80,347.75 -17.5%0.7%0.4 $0.86 5/15/2022113,600 shares $103,353.28 -6.0%0.8%0.4 $0.91 4/30/2022120,900 shares $145,080.00 -35.7%0.9%0.3 $1.20 4/15/2022188,100 shares $253,935.00 -30.8%1.4%0.3 $1.35 3/31/2022271,800 shares $353,340.00 -39.3%2.0%0.4 $1.30 3/15/2022447,700 shares $555,148.00 +0.5%5.6%0.2 $1.24 2/28/2022445,400 shares $454,308.00 -19.9%5.6%0.1 $1.02 2/15/2022555,700 shares $683,511.00 +5.9%6.9%0.1 $1.23 1/31/2022524,900 shares $677,121.00 +43.0%6.5%0.1 $1.29 1/15/2022367,000 shares $506,460.00 -64.0%4.5%0.1 $1.38 12/31/20211,020,000 shares $1.81 million No Change22.1%0.2 $1.77 KTTA Short Interest - Frequently Asked Questions What is Pasithea Therapeutics' current short interest? Short interest is the volume of Pasithea Therapeutics shares that have been sold short but have not yet been closed out or covered. As of October 31st, investors have sold 11,600 shares of KTTA short. 1.45% of Pasithea Therapeutics' shares are currently sold short. Learn More on Pasithea Therapeutics' current short interest. What is a good short interest percentage for Pasithea Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 1.45% of Pasithea Therapeutics' floating shares are currently sold short. Is Pasithea Therapeutics' short interest increasing or decreasing? Pasithea Therapeutics saw a decline in short interest in October. As of October 31st, there was short interest totaling 11,600 shares, a decline of 49.1% from the previous total of 22,800 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Pasithea Therapeutics' float size? Pasithea Therapeutics currently has issued a total of 1,266,000 shares. Some of Pasithea Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Pasithea Therapeutics currently has a public float of 802,500 shares. How does Pasithea Therapeutics' short interest compare to its competitors? 1.45% of Pasithea Therapeutics' shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Pasithea Therapeutics: Vaccinex, Inc. (9.11%), TransCode Therapeutics, Inc. (4.31%), Mannatech, Incorporated (0.19%), IN8bio, Inc. (3.12%), TherapeuticsMD, Inc. (0.26%), Kazia Therapeutics Limited (0.71%), Minerva Neurosciences, Inc. (0.13%), NRx Pharmaceuticals, Inc. (8.64%), PharmaCyte Biotech, Inc. (0.87%), Exicure, Inc. (4.71%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.08 billion), AppLovin Co. ($3.18 billion), Paychex, Inc. ($2.64 billion), Nu Holdings Ltd. ($2.54 billion), International Paper ($2.46 billion), Cencora, Inc. ($2.27 billion), Moderna, Inc. ($1.87 billion), SoFi Technologies, Inc. ($1.81 billion), Lululemon Athletica Inc. ($1.75 billion), and Onsemi ($1.71 billion). View all of the most shorted stocks. What does it mean to sell short Pasithea Therapeutics stock? Short selling KTTA is an investing strategy that aims to generate trading profit from Pasithea Therapeutics as its price is falling. KTTA shares are trading up $0.04 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Pasithea Therapeutics? A short squeeze for Pasithea Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of KTTA, which in turn drives the price of the stock up even further. How often is Pasithea Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including KTTA, twice per month. The most recent reporting period available is October, 31 2024. More Short Interest Resources from MarketBeat Related Companies VCNX Short Squeeze RNAZ Short Squeeze APRE Short Squeeze MTEX Short Squeeze BGXX Short Squeeze INAB Short Squeeze NERV Short Squeeze TXMD Short Squeeze AKTX Short Squeeze NRXP Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:KTTA) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Pasithea Therapeutics Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Pasithea Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.